Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release

Muwan Chen,1,2 Dang QS Le,1,2 San Hein,2 Pengcheng Li,1 Jens V Nygaard,2 Moustapha Kassem,3 Jørgen Kjems,2 Flemming Besenbacher,2 Cody Bünger11Orthopaedic Research Lab, Aarhus University Hospital, Aarhus C, Denmark; 2Interdisciplinary Nanoscience Center (iNANO), Aarhus Un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen M, Le DQ, Hein S, Li P, Nygaard JV, Kassem M, Kjems J, Besenbacher F, Bünger C
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/6ba4925e3b4f44e9b0810d7939608112
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6ba4925e3b4f44e9b0810d7939608112
record_format dspace
spelling oai:doaj.org-article:6ba4925e3b4f44e9b0810d79396081122021-12-02T05:16:52ZFabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release1176-91141178-2013https://doaj.org/article/6ba4925e3b4f44e9b0810d79396081122012-08-01T00:00:00Zhttp://www.dovepress.com/fabrication-and-characterization-of-a-rapid-prototyped-tissue-engineer-a10608https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Muwan Chen,1,2 Dang QS Le,1,2 San Hein,2 Pengcheng Li,1 Jens V Nygaard,2 Moustapha Kassem,3 Jørgen Kjems,2 Flemming Besenbacher,2 Cody Bünger11Orthopaedic Research Lab, Aarhus University Hospital, Aarhus C, Denmark; 2Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark; 3Department of Endocrinology and Metabolism, Odense University Hospital, Odense C, DenmarkAbstract: Bone tissue engineering implants with sustained local drug delivery provide an opportunity for better postoperative care for bone tumor patients because these implants offer sustained drug release at the tumor site and reduce systemic side effects. A rapid prototyped macroporous polycaprolactone scaffold was embedded with a porous matrix composed of chitosan, nanoclay, and β-tricalcium phosphate by freeze-drying. This composite scaffold was evaluated on its ability to deliver an anthracycline antibiotic and to promote formation of mineralized matrix in vitro. Scanning electronic microscopy, confocal imaging, and DNA quantification confirmed that immortalized human bone marrow-derived mesenchymal stem cells (hMSC-TERT) cultured in the scaffold showed high cell viability and growth, and good cell infiltration to the pores of the scaffold. Alkaline phosphatase activity and osteocalcin staining showed that the scaffold was osteoinductive. The drug-release kinetics was investigated by loading doxorubicin into the scaffold. The scaffolds comprising nanoclay released up to 45% of the drug for up to 2 months, while the scaffold without nanoclay released 95% of the drug within 4 days. Therefore, this scaffold can fulfill the requirements for both bone tissue engineering and local sustained release of an anticancer drug in vitro. These results suggest that the scaffold can be used clinically in reconstructive surgery after bone tumor resection. Moreover, by changing the composition and amount of individual components, the scaffold can find application in other tissue engineering areas that need local sustained release of drug.Keywords: nanoclay, chitosan, scaffold, tissue engineering, drug delivery systemChen MLe DQHein SLi PNygaard JVKassem MKjems JBesenbacher FBünger CDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 4285-4297 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Chen M
Le DQ
Hein S
Li P
Nygaard JV
Kassem M
Kjems J
Besenbacher F
Bünger C
Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
description Muwan Chen,1,2 Dang QS Le,1,2 San Hein,2 Pengcheng Li,1 Jens V Nygaard,2 Moustapha Kassem,3 Jørgen Kjems,2 Flemming Besenbacher,2 Cody Bünger11Orthopaedic Research Lab, Aarhus University Hospital, Aarhus C, Denmark; 2Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus C, Denmark; 3Department of Endocrinology and Metabolism, Odense University Hospital, Odense C, DenmarkAbstract: Bone tissue engineering implants with sustained local drug delivery provide an opportunity for better postoperative care for bone tumor patients because these implants offer sustained drug release at the tumor site and reduce systemic side effects. A rapid prototyped macroporous polycaprolactone scaffold was embedded with a porous matrix composed of chitosan, nanoclay, and β-tricalcium phosphate by freeze-drying. This composite scaffold was evaluated on its ability to deliver an anthracycline antibiotic and to promote formation of mineralized matrix in vitro. Scanning electronic microscopy, confocal imaging, and DNA quantification confirmed that immortalized human bone marrow-derived mesenchymal stem cells (hMSC-TERT) cultured in the scaffold showed high cell viability and growth, and good cell infiltration to the pores of the scaffold. Alkaline phosphatase activity and osteocalcin staining showed that the scaffold was osteoinductive. The drug-release kinetics was investigated by loading doxorubicin into the scaffold. The scaffolds comprising nanoclay released up to 45% of the drug for up to 2 months, while the scaffold without nanoclay released 95% of the drug within 4 days. Therefore, this scaffold can fulfill the requirements for both bone tissue engineering and local sustained release of an anticancer drug in vitro. These results suggest that the scaffold can be used clinically in reconstructive surgery after bone tumor resection. Moreover, by changing the composition and amount of individual components, the scaffold can find application in other tissue engineering areas that need local sustained release of drug.Keywords: nanoclay, chitosan, scaffold, tissue engineering, drug delivery system
format article
author Chen M
Le DQ
Hein S
Li P
Nygaard JV
Kassem M
Kjems J
Besenbacher F
Bünger C
author_facet Chen M
Le DQ
Hein S
Li P
Nygaard JV
Kassem M
Kjems J
Besenbacher F
Bünger C
author_sort Chen M
title Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
title_short Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
title_full Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
title_fullStr Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
title_full_unstemmed Fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
title_sort fabrication and characterization of a rapid prototyped tissue engineering scaffold with embedded multicomponent matrix for controlled drug release
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/6ba4925e3b4f44e9b0810d7939608112
work_keys_str_mv AT chenm fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT ledq fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT heins fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT lip fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT nygaardjv fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT kassemm fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT kjemsj fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT besenbacherf fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
AT bampuumlngerc fabricationandcharacterizationofarapidprototypedtissueengineeringscaffoldwithembeddedmulticomponentmatrixforcontrolleddrugrelease
_version_ 1718400475924004864